The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib trial of atezolizumab in combination with nab-paclitaxel in patients with metastatic triple-negative breast cancer (mTNBC).
 
Sylvia Adams
Research Funding - Genentech; Merck
 
Jennifer Robinson Diamond
Research Funding - Casi Pharmaceuticals
 
Erika Paige Hamilton
No Relationships to Disclose
 
Paula Raffin Pohlmann
Leadership - Immunonet BioSciences
Stock and Other Ownership Interests - Immunonet BioSciences
Consulting or Advisory Role - Immunonet BioSciences; OncoPlex Diagnostics; Personalized Cancer Therapy
Patents, Royalties, Other Intellectual Property - IMMUNOLOGICAL COMPOSITIONS AS CANCER BIOMARKERS AND/OR THERAPEUTICS; U.S. Patent and Trademark Office No. US 20120201820. Invention title: Immunological Compositions as Cancer Therapeutics.
 
Sara M. Tolaney
No Relationships to Disclose
 
Luciana Molinero
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Research Funding - Genentech
 
Xian He
Employment - Genentech
 
Daniel Waterkamp
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Roel Peter Funke
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
John D. Powderly
Employment - BioCytics; Carolina BioOncology Institute
Leadership - BioCytics; Carolina BioOncology Institute
Stock and Other Ownership Interests - BioCytics; Bluebird Bio; Carolina BioOncology Institute; Juno Therapeutics; Kite, a Gilead company; Lion Biotechnologies; ZIOPHARM Oncology
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Curis; Genentech/Roche; TopAlliance BioSciences Inc
Speakers' Bureau - Bristol-Myers Squibb; Dendreon; Genentech/Roche; Merck
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Incyte; Lilly/ImClone; Macrogenics
Patents, Royalties, Other Intellectual Property - BioCytics is developing intellectual property for cellular immunotherapy